Sanofi Genzyme Bioventures

logo_sanofi-genzyme-bioventures
Sanofi-Genzyme BioVentures (SGBV) is the corporate venture capital arm of Sanofi. Previously known as Genzyme Ventures, SGBV has an expanded mandate to invest across the broad business footprint of Sanofi. SGBV only invests in early stage companies with promising new products that may be future Sanofi pipeline candidates. Today, SGBV has assembled a portfolio of direct equity investments in a variety of promising innovative life-science companies.SGBV is an important component of Sanofi’s broader global strategy to invigorate external innovation. In addition to engaging in venture capital, SGBV provides transaction support for equity investments made by other groups within Sanofi.

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services

This information will not be shared with third parties